Cytarabine-induced aseptic meningitis.
van den Berg
H
H
van der Flier
M
M
van de Wetering
M D
MD
D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015448:Leukemia, B-Cell / Q000188:drug therapy*; D008582:Meningitis, Aseptic / Q000139:chemically induced*
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine